Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
Jun 04, 2020
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
May 28, 2020
Provention Bio to Present at the Jefferies Virtual Healthcare Conference
May 19, 2020
Autoimmune Disease Diagnostics Market Study, 2015-2025 Featuring Profiles of Leading Players Including Siemens, Abbott, Bio-Rad Labs, Pfizer, and Johnson & Johnson
May 13, 2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team
Apr 30, 2020
Provention Bio to Report First Quarter 2020 Financial Results and Host Conference Call on Thursday, May 7, 2020
Apr 20, 2020
The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%
Apr 10, 2020
Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets(TM)
Mar 25, 2020
The Global Autoimmune Treatment Market is expected to grow from USD 142,236.21 Million in 2018 to USD 232,125.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%
Mar 24, 2020
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Jan 10, 2020
Mymee Relaunches Website to Support Patient-Centric Approach to Autoimmune Disease
Nov 08, 2019
Global $18 Billion Autoimmune Disease Diagnostic Markets to 2026
Oct 03, 2019
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
Aug 15, 2019
The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period
Jun 10, 2019
Rheumatoid Arthritis - Can its Onset be Delayed or Prevented
Jun 06, 2019
Mymee, Inc. Expands Executive Leadership Team to Support Commercial Growth
Apr 26, 2019
Bone Abnormalities in Systemic Autoimmune Disease
Mar 28, 2019
Provention Bio Appoints Jeffrey Bluestone, PhD, to Board of Directors
Dec 06, 2018
Berlin Cures' Steering Committee is Assembled to Facilitate the Design and Implementation of Phase 2 Study of BC 007
Aug 30, 2018
Regen BioPharma, Inc. Reports Success of its NR2F6 Small Molecule Screening Program for Treating Autoimmune Diseases